• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?

作者信息

Arboleda John F, Urcuqui-Inchima Silvio

机构信息

Group of Immunovirology, Faculty of Medicine, University of Antioquia, Medellin, Colombia.

Behavioural Science and Health Care Habits Unit, Comfama, Medellin, Colombia.

出版信息

Front Immunol. 2020 Jun 23;11:1523. doi: 10.3389/fimmu.2020.01523. eCollection 2020.

DOI:10.3389/fimmu.2020.01523
PMID:32655583
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7324720/
Abstract
摘要

相似文献

1
Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?补充维生素D：一种治疗冠状病毒/新冠病毒的潜在方法？
Front Immunol. 2020 Jun 23;11:1523. doi: 10.3389/fimmu.2020.01523. eCollection 2020.
2
Can a Combination of AT1R Antagonist and Vitamin D Treat the Lung Complication of COVID-19?血管紧张素Ⅱ受体拮抗剂与维生素 D 联合治疗 COVID-19 肺部并发症？
Am J Med Sci. 2020 Oct;360(4):338-341. doi: 10.1016/j.amjms.2020.07.018. Epub 2020 Jul 15.
3
A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.维生素 D 与血管紧张素转换酶 2 相互作用的简要综述：COVID-19 潜在治疗方法的启示。
Rev Med Virol. 2020 Sep;30(5):e2119. doi: 10.1002/rmv.2119. Epub 2020 Jun 25.
4
COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response.新型冠状病毒肺炎与相对血管紧张素转换酶2缺乏：在疾病严重程度和治疗反应中的作用
Open Heart. 2020 Jun;7(1). doi: 10.1136/openhrt-2020-001302.
5
Vitamin D and COVID-19: Lessons from Spaceflight Analogs.维生素D与2019冠状病毒病：航天模拟实验的经验教训
J Nutr. 2020 Oct 12;150(10):2624-2627. doi: 10.1093/jn/nxaa233.
6
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.血管紧张素转换酶 2 的器官保护作用及其对 COVID-19 预后的影响。
J Med Virol. 2020 Jul;92(7):726-730. doi: 10.1002/jmv.25785. Epub 2020 Apr 5.
7
The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19.肾素-血管紧张素-醛固酮系统：在 COVID-19 中的发病机制中的作用及潜在治疗靶点。
Pharmacol Res Perspect. 2020 Aug;8(4):e00623. doi: 10.1002/prp2.623.
8
Can beta-adrenergic blockers be used in the treatment of COVID-19?β-肾上腺素能阻滞剂可用于治疗新型冠状病毒肺炎吗？
Med Hypotheses. 2020 Sep;142:109809. doi: 10.1016/j.mehy.2020.109809. Epub 2020 May 5.
9
Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.肾素-血管紧张素系统抑制在 COVID-19 大流行期间的争议。
Nat Rev Nephrol. 2020 Jun;16(6):305-307. doi: 10.1038/s41581-020-0279-4.
10
Cancer therapy and treatments during COVID-19 era.新冠疫情时代的癌症治疗与疗法
Adv Biol Regul. 2020 Aug;77:100739. doi: 10.1016/j.jbior.2020.100739. Epub 2020 Jun 26.

引用本文的文献

1
Effect of vitamin D supplementation on COVID-19 outcomes: an umbrella review of systematic reviews.补充维生素D对COVID-19结局的影响：系统评价的伞状综述
Front Nutr. 2025 Jun 13;12:1559471. doi: 10.3389/fnut.2025.1559471. eCollection 2025.
2
Vitamin D: A key player in COVID-19 immunity and lessons from the pandemic to combat immune-evasive variants.维生素 D：在 COVID-19 免疫中的关键角色，以及从大流行中吸取的对抗免疫逃避变异体的经验教训。
Inflammopharmacology. 2024 Dec;32(6):3631-3652. doi: 10.1007/s10787-024-01578-w. Epub 2024 Oct 16.
3
Assessment of Supplementation with Different Biomolecules in the Prevention and Treatment of COVID-19.评估不同生物分子在 COVID-19 预防和治疗中的补充作用。
Nutrients. 2024 Sep 11;16(18):3070. doi: 10.3390/nu16183070.
4
Novel antioxidant protein target therapy to counter the prevalence and severity of SARS-CoV-2.新型抗氧化蛋白靶向治疗，应对 SARS-CoV-2 的流行和严重程度。
Front Immunol. 2024 Jan 3;14:1241313. doi: 10.3389/fimmu.2023.1241313. eCollection 2023.
5
Surfactant replacement therapy as promising treatment for COVID-19: an updated narrative review.表面活性物质替代疗法作为 COVID-19 的有前途的治疗方法：更新的叙述性综述。
Biosci Rep. 2023 Aug 31;43(8). doi: 10.1042/BSR20230504.
6
Vitamin D, Albumin, and D-Dimer as Significant Prognostic Markers in Early Hospitalization in Patients with COVID-19.维生素D、白蛋白和D-二聚体作为COVID-19患者早期住院时的重要预后标志物
J Clin Med. 2023 Apr 12;12(8):2825. doi: 10.3390/jcm12082825.
7
The association between vitamin D intake with inflammatory and biochemical indices and mortality in critically ill patients with COVID-19: A case-control study.维生素 D 摄入与 COVID-19 重症患者的炎症和生化指标及死亡率的关系：一项病例对照研究。
Immun Inflamm Dis. 2023 Apr;11(4):e844. doi: 10.1002/iid3.844.
8
Vitamin D3 and COVID-19 Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses.维生素D3与新冠病毒病结局：系统评价与荟萃分析的伞状综述
Antioxidants (Basel). 2023 Jan 22;12(2):247. doi: 10.3390/antiox12020247.
9
Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease.维生素 D 状态和补充对炎症性肠病患者队列中 SARS-CoV-2 感染风险和 COVID-19 症状的可能影响。
Nutrients. 2022 Dec 29;15(1):169. doi: 10.3390/nu15010169.
10
Vitamin D-A prominent immunomodulator to prevent COVID-19 infection.维生素 D - 预防 COVID-19 感染的主要免疫调节剂。
Int J Rheum Dis. 2023 Jan;26(1):13-30. doi: 10.1111/1756-185X.14477. Epub 2022 Oct 29.

本文引用的文献

1
The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality.维生素 D 在预防 2019 年冠状病毒病感染和死亡中的作用。
Aging Clin Exp Res. 2020 Jul;32(7):1195-1198. doi: 10.1007/s40520-020-01570-8. Epub 2020 May 6.
2
Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19.假说：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂可能会增加 COVID-19 重症风险。
J Travel Med. 2020 May 18;27(3). doi: 10.1093/jtm/taaa041.
3
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
4
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.2019 冠状病毒病（COVID-19）疫情的起源、传播和临床治疗——现状更新。
Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0.
5
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms.新型冠状病毒（COVID-19）感染中枢神经系统的证据：组织分布、宿主-病毒相互作用及潜在神经嗜性机制。
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998. doi: 10.1021/acschemneuro.0c00122. Epub 2020 Mar 13.
6
Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?可溶性血管紧张素转化酶 2：冠状病毒感染治疗的潜在方法？
Clin Sci (Lond). 2020 Mar 13;134(5):543-545. doi: 10.1042/CS20200163.
7
Therapeutic options for the 2019 novel coronavirus (2019-nCoV).2019新型冠状病毒（2019-nCoV）的治疗选择。
Nat Rev Drug Discov. 2020 Mar;19(3):149-150. doi: 10.1038/d41573-020-00016-0.
8
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病（COVID-19）疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
9
Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies.基于 SARS-CoV 免疫学研究的 COVID-19 冠状病毒（SARS-CoV-2）潜在疫苗靶点的初步鉴定。
Viruses. 2020 Feb 25;12(3):254. doi: 10.3390/v12030254.
10
Structure analysis of the receptor binding of 2019-nCoV.2019新型冠状病毒受体结合的结构分析
Biochem Biophys Res Commun. 2020 Feb 17;525(1):135-40. doi: 10.1016/j.bbrc.2020.02.071.